• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case-Control Study.皮肌炎合并间质性肺疾病的临床特征:一项回顾性病例对照研究
Rheumatol Ther. 2023 Jun;10(3):635-648. doi: 10.1007/s40744-023-00540-6. Epub 2023 Feb 18.
2
Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study.临床无肌病性皮肌炎与经典皮肌炎特征及抗 MDA5 抗体分布和疗效比较:一项回顾性病例对照研究。
Front Immunol. 2023 Nov 27;14:1237209. doi: 10.3389/fimmu.2023.1237209. eCollection 2023.
3
Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study.抗 MDA-5 抗体相关性肌炎成人和儿童的疾病特征和临床转归:一项前瞻性观察性的两中心研究。
Rheumatol Int. 2022 Jul;42(7):1155-1165. doi: 10.1007/s00296-021-04897-1. Epub 2021 May 29.
4
Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease.抗 MDA5 阳性伴间质性肺病的无肌病性皮肌炎中抗 Ro52 抗体的预后价值。
Rheumatology (Oxford). 2021 Jul 1;60(7):3343-3351. doi: 10.1093/rheumatology/keaa786.
5
[Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].临床无肌病性皮肌炎与典型皮肌炎的临床及免疫学特征比较
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Dec 18;52(6):1001-1008. doi: 10.19723/j.issn.1671-167X.2020.06.003.
6
Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody-Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk.抗MDA5抗体阳性皮肌炎中抗Ro52抗体的共存与快速进展性间质性肺病及死亡风险高度相关。
J Rheumatol. 2023 Feb;50(2):219-226. doi: 10.3899/jrheum.220139. Epub 2022 Jun 15.
7
Associations between anti-melanoma differentiation-associated gene 5 antibody and demographics, clinical characteristics and laboratory results of patients with dermatomyositis: A systematic meta-analysis.抗黑色素瘤分化相关基因 5 抗体与皮肌炎患者的人口统计学、临床特征和实验室结果的关联:系统荟萃分析。
J Dermatol. 2018 Jan;45(1):46-52. doi: 10.1111/1346-8138.14092. Epub 2017 Oct 6.
8
Anti-MDA5 and anti-SSA/Ro52 antibodies double-positive dermatomyositis overlapping with rheumatoid arthritis-associated interstitial lung disease: A case report.抗 MDA5 和抗 SSA/Ro52 抗体双阳性皮肌炎重叠类风湿关节炎相关间质性肺病:一例报告。
Int J Rheum Dis. 2022 Dec;25(12):1437-1440. doi: 10.1111/1756-185X.14430. Epub 2022 Aug 27.
9
A Case of Dermatomyositis with Coexistence of Positive Anti-MDA5 Antibodies and Anti-SSA/RO52 Antibodies, Combined with Necrotic Skin Ulcers.1例皮肌炎合并抗MDA5抗体和抗SSA/RO52抗体阳性及坏死性皮肤溃疡
Int Med Case Rep J. 2024 Jan 6;17:9-15. doi: 10.2147/IMCRJ.S441691. eCollection 2024.
10
Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.抗 MDA5 抗体阳性皮肌炎相关间质性肺病患者血清几丁质酶水平的临床意义。
J Rheumatol. 2019 Aug;46(8):935-942. doi: 10.3899/jrheum.180825. Epub 2019 May 15.

引用本文的文献

1
The clinical features and mortality predictors for idiopathic inflammatory myopathies: a retrospective study of 572 patients and the "AIRMT" Score.特发性炎性肌病的临床特征及死亡预测因素:一项对572例患者的回顾性研究及“AIRMT”评分
Clin Rheumatol. 2025 Jul 2. doi: 10.1007/s10067-025-07495-9.
2
Severe interstitial lung disease risk prediction in anti-melanoma differentiation-associated protein 5 positive dermatomyositis: the STRAD-Ro52 model.抗黑色素瘤分化相关蛋白5阳性皮肌炎中重症间质性肺疾病风险预测:STRAD-Ro52模型
Ann Med. 2025 Dec;57(1):2440621. doi: 10.1080/07853890.2024.2440621. Epub 2024 Dec 19.
3
The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease: Focusing on Molecular Mechanisms and Potential Treatment Strategies.巨噬细胞在结缔组织病相关间质性肺疾病中的作用:聚焦于分子机制和潜在治疗策略。
Int J Mol Sci. 2023 Jul 26;24(15):11995. doi: 10.3390/ijms241511995.

本文引用的文献

1
Pathogenesis of anti-melanoma differentiation-associated gene-5 (MDA5) dermatomyositis.抗黑色素瘤分化相关基因5(MDA5)皮肌炎的发病机制。
Chin Med J (Engl). 2022 Sep 20;135(18):2188-2190. doi: 10.1097/CM9.0000000000002049.
2
Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease.抗 MDA5 阳性伴间质性肺病的无肌病性皮肌炎中抗 Ro52 抗体的预后价值。
Rheumatology (Oxford). 2021 Jul 1;60(7):3343-3351. doi: 10.1093/rheumatology/keaa786.
3
What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?在新冠病毒病(COVID-19)的治疗中,我们能从与抗黑色素瘤分化相关基因5(anti-MDA5)皮肌炎相关的快速进展性间质性肺疾病中学到什么?
Autoimmun Rev. 2020 Nov;19(11):102666. doi: 10.1016/j.autrev.2020.102666. Epub 2020 Sep 14.
4
Malignancy in dermatomyositis: A retrospective paired case-control study of 202 patients from Central China.皮肌炎中的恶性肿瘤:一项对来自中国中部地区202例患者的回顾性配对病例对照研究。
Medicine (Baltimore). 2020 Aug 21;99(34):e21733. doi: 10.1097/MD.0000000000021733.
5
Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease: The FLAIR Model.无肌病性皮肌炎相关间质性肺病患者的死亡率预测:FLAIR 模型。
Chest. 2020 Oct;158(4):1535-1545. doi: 10.1016/j.chest.2020.04.057. Epub 2020 May 16.
6
Dermatomyositis: An Update on Diagnosis and Treatment.皮肌炎:诊断与治疗的最新进展。
Am J Clin Dermatol. 2020 Jun;21(3):339-353. doi: 10.1007/s40257-020-00502-6.
7
Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease.托法替布治疗无肌病性皮肌炎相关间质性肺疾病
N Engl J Med. 2019 Jul 18;381(3):291-293. doi: 10.1056/NEJMc1900045.
8
Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis.血清中新蝶呤以及铁蛋白、可溶性白细胞介素-2 受体、KL-6 和抗 MDA5 抗体滴度为合并抗 MDA5 抗体阳性皮肌炎的间质性肺疾病患者对治疗应答的标志物。
Mod Rheumatol. 2019 Sep;29(5):814-820. doi: 10.1080/14397595.2018.1548918. Epub 2019 Feb 7.
9
Evidence supports blind screening for internal malignancy in dermatomyositis: Data from 2 large US dermatology cohorts.有证据支持对皮肌炎患者进行隐匿性内脏恶性肿瘤筛查:来自美国两个大型皮肤科队列的数据。
Medicine (Baltimore). 2018 Jan;97(2):e9639. doi: 10.1097/MD.0000000000009639.
10
Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features.抗黑色素瘤分化相关基因 5(MDA5)皮肌炎:简明综述,重点介绍独特的临床特征。
J Am Acad Dermatol. 2018 Apr;78(4):776-785. doi: 10.1016/j.jaad.2017.12.010. Epub 2017 Dec 9.

皮肌炎合并间质性肺疾病的临床特征:一项回顾性病例对照研究

Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case-Control Study.

作者信息

Weng Chenghua, Ding Zongnan, Zhou Yiqun, Yang Qinyi, Xue Leixi, Zhang Lei, Wang Gang, Liu Zhichun

机构信息

Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Sanxiang Road No.1055, Suzhou, 215000, Jiangsu, China.

出版信息

Rheumatol Ther. 2023 Jun;10(3):635-648. doi: 10.1007/s40744-023-00540-6. Epub 2023 Feb 18.

DOI:10.1007/s40744-023-00540-6
PMID:36802052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10140193/
Abstract

INTRODUCTION

Interstitial lung disease (ILD) is a common complication of dermatomyositis (DM) and one of the main risk factors for poor prognosis in DM patients. The aim of this study was to reveal the clinical characteristics of DM patients with ILD.

METHODS

Clinical data from the Second Affiliated Hospital of Soochow University were used to conduct a retrospective case-control study. Univariate and multivariate logistic regression analysis were performed to identify risk factors for ILD in DM.

RESULTS

A total of 78 DM patients were included in this study, including 38 DM patients with ILD and 40 DM patients without ILD. Compared with patients without ILD, patients with ILD were older (59.6 vs. 51.2 years, P = 0.004), and had higher rates of clinically amyopathic DM (CADM) (45 vs. 20%, P = 0.019), Gottron's papules (76 vs. 53%, P = 0.028), mechanic's hands (13 vs. 0%, P = 0.018), myocardial involvement (29 vs. 8%, P = 0.014), and higher positive rates of anti-SSA/Ro52 (74 vs. 20%, P < 0.001) and anti-melanoma differentiation-associated gene-5 (MDA5) (24 vs. 8%, P = 0.048) antibodies, while albumin (ALB) (34.5 vs. 38.0 g/l, P = 0.006), prognostic nutritional index (PNI) (40.3 vs. 44.7, P = 0.013), the rates of muscle weakness (45 vs. 73%, P = 0.013) and heliotrope rash (50 vs. 80%, P = 0.005) were lower. In addition, the five patients who died were all DM patients with ILD (13 vs. 0%, P = 0.018). Multivariate logistic regression showed that old age (odds ratio [OR] = 1.119, 95% confidence interval [CI] = 1.028-1.217, P = 0.009), Gottron's papules (OR = 8.302, 95% CI = 1.275-54.064, P = 0.027) and anti-SSA/Ro52 (OR = 24.320, 95% CI = 4.102-144.204, P < 0.001) were independent risk factors for ILD in DM.

CONCLUSIONS

DM patients with ILD usually present with older age, higher rates of CADM, Gottron's papules, mechanic's hands, myocardial involvement, higher positive rates of anti-MDA5 and anti-SSA/Ro52 antibodies, lower ALB, PNI, and lower rates of muscle weakness and heliotrope rash. Old age, Gottron's papules, and anti-SSA/Ro52 were independent risk factors for ILD in DM.

摘要

引言

间质性肺病(ILD)是皮肌炎(DM)的常见并发症,也是DM患者预后不良的主要危险因素之一。本研究旨在揭示合并ILD的DM患者的临床特征。

方法

利用苏州大学附属第二医院的临床数据进行回顾性病例对照研究。采用单因素和多因素逻辑回归分析确定DM患者发生ILD的危险因素。

结果

本研究共纳入78例DM患者,其中38例合并ILD,40例未合并ILD。与未合并ILD的患者相比,合并ILD的患者年龄更大(59.6岁对51.2岁,P = 0.004),临床无肌病性DM(CADM)发生率更高(45%对20%,P = 0.019),Gottron丘疹发生率更高(76%对53%,P = 0.028),技工手发生率更高(13%对0%,P = 0.018),心肌受累发生率更高(29%对8%,P = 0.014),抗SSA/Ro52抗体阳性率更高(74%对20%,P < 0.001),抗黑色素瘤分化相关基因5(MDA5)抗体阳性率更高(24%对8%,P = 0.048),而白蛋白(ALB)水平更低(34.5g/L对38.0g/L,P = 0.006),预后营养指数(PNI)更低(40.3对44.7,P = 0.013),肌无力发生率更低(45%对73%,P = 0.013),向阳疹发生率更低(50%对80%,P = 0.005)。此外,死亡的5例患者均为合并ILD的DM患者(13%对0%,P = 0.018)。多因素逻辑回归显示,年龄较大(比值比[OR]=1.119,95%置信区间[CI]=1.028 - 1.217,P = 0.009)、Gottron丘疹(OR = 8.302,95%CI = 1.275 - 54.064,P = 0.027)和抗SSA/Ro52(OR = 24.320,95%CI = 4.102 - 144.204,P < 0.001)是DM患者发生ILD的独立危险因素。

结论

合并ILD的DM患者通常年龄较大,CADM、Gottron丘疹、技工手、心肌受累发生率更高,抗MDA5和抗SSA/Ro52抗体阳性率更高,ALB、PNI更低,肌无力和向阳疹发生率更低。年龄较大、Gottron丘疹和抗SSA/Ro52是DM患者发生ILD的独立危险因素。